Study of Nitazoxanide (NTZ) for Helicobacter Pylori in Children
NCT ID: NCT04415983
Last Updated: 2020-06-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
100 participants
INTERVENTIONAL
2020-06-01
2030-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study of Nitazoxanide (NTZ) Based New Therapeutic Regimens for Helicobacter Pylori
NCT02422706
A Two Week Nitazoxanidebased Quadruple Regimen
NCT02621359
Efficacy of Nitazoxanide Based Therapy vs Standard Triple Therapy in H-pylori in Children
NCT07086937
Safety and Efficacy of Triple and Quadruple Regimens as First Line Therapy for Management of Helicobacter Pylori Infection in Egyptians
NCT06315478
A Unique Regimen for Treatment of Helicobacter Pylori Infection
NCT03491995
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Nitazoxanide group
Clarithromycin, Nitazoxanide and Proton pump inhibitor
Nitazoxanide
Nitazoxanide twice daily
Clarithromycin
Klacid twice daily
Proton pump inhibitor
Omeprazoe twice daily
Traditional group
Clarithromycin, Metronidazole and Proton pump inhibitor
Clarithromycin
Klacid twice daily
Metronidazole
Metronidazole twice daily
Proton pump inhibitor
Omeprazoe twice daily
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nitazoxanide
Nitazoxanide twice daily
Clarithromycin
Klacid twice daily
Metronidazole
Metronidazole twice daily
Proton pump inhibitor
Omeprazoe twice daily
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sherief Abd-Elsalam
Ass. Prof. Tropical Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rasha Gamal, Ass. Prof.
Role: PRINCIPAL_INVESTIGATOR
Pediatrics department - Tanta University
sherief Abd-Elsalam, ass. Prof.
Role: PRINCIPAL_INVESTIGATOR
Tanta University Faculty of medicine
Abeer Salamah, Lecturer
Role: STUDY_DIRECTOR
Pediatrics department - Kafr Elsheikh University
dina shawky, lecturer
Role: STUDY_DIRECTOR
Pediatrics department - Tanta University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sherief Abd-Elsalam
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
helicobacter children
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.